Table 4.
Multivariate analysis of factors associated with log-NLR.
| β (95% CI) | p-value | |
|---|---|---|
| eGFR (ml·min−1·1.73 m−2) | −0.003 (−0.005 ∼ −0.001) | 0.004 |
| WBC (×102/μL) | 0.004 (0.001 ∼ 0.006) | 0.004 |
| Calcium channel blockers | 0.058 (−0.019 ∼ 0.135) | 0.137 |
| Hb (g/dL) | −0.016 (−0.039 ∼ 0.007) | 0.176 |
| Cerebral infarction | 0.077 (−0.038 ∼ 0.192) | 0.185 |
| ACEI | 0.058 (−0.068 ∼ 0.184) | 0.361 |
| RDW-CV | 0.014 (−0.026 ∼ 0.054) | 0.496 |
| Insulin | 0.076 (−0.168 ∼ 0.320) | 0.536 |
| Peripheral artery disease | −0.032 (−0.156 ∼ 0.093) | 0.617 |
| Diabetes mellitus | −0.018 (−0.110 ∼ 0.074) | 0.693 |
| Diuretics | 0.005 (−0.086 ∼ 0.096) | 0.912 |
β: regression coefficient of multiple linear regression analysis; 95% CI: 95% confidence interval; ACEI: angiotensin-converting enzyme inhibitor; eGFR: estimated glomerular filtration rate; Hb: hemoglobin; log-NLR: log-transformed neutrophil/lymphocyte ratio; RDW-CV: coefficient of variation of red cell distribution width; WBC: white blood cells.